On July 1, 2024, the annual call for proposals to the UK National Screening Committee (UK NSC) was launched. During the call, stakeholders can propose potential new screening topics or modifications of existing screening programs. The deadline for applications is September 30, 2024.

On June 19, 2024, the Order SND/606/2024, of June 13, came into force. This Order, among other things, amends Annexes I, II, III, VI, and VII of Royal Decree 1030/2006, of September 15, which establishes the Common Package of Benefits of the National Health System and the procedure for its update. The changes mostly concern in-vitro diagnostics, ENT, pulmonary and airways, cardiovascular, and some other fields.

On July 1, 2024, the National Institute for Health and Disability Insurance (INAMI/RIZIV) introduced a new agreement (Convention), which allows permanent reimbursement for molecular biology tests by next-generation sequencing (NGS) in oncology and hemato-oncology. The tests were reimbursed temporarily in the context of the pilot Convention from 2019. Fifty-one new pseudo-nomenclature codes with tariffs were introduced. The pseudocode descriptions specify the indication, while certain biomarkers and reimbursement conditions are mentioned as notes to the code.

In June 2024, the National Institute for Health and Care Research (NIHR) in England released three MedTech-related assessments in its Health Technology Assessment (HTA) Journal, which concerned management for non-acute anterior cruciate ligament injury, laparoscopic cholecystectomy, and antenatal/newborn screening programs. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

In June 2024, the Finnish Coordinating Center for Health Technology Assessment announced that two rapid hospital assessments in the extracorporeal treatments and endoscopy fields and one Digi-HTA were accomplished.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in June 2024. Twelve recommendations were published concerning the registration of medical devices or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular and endocrine devices, as well as medical aids.

In June 2024, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedures Guidance concerning minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 13540 of June 18, 2024, Tuscany Regional Healthcare published two new assessments and two reassessments of medical devices in the endoscopy, peripheral vascular, and ICU/OR areas.

On June 18, 2024, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the information about the status of the ongoing structural reform of the Nomenclature started in 2019. INAMI/RIZIV reported on activities already completed as of June 2024 and announced further steps.

The Danish Health Data Authority quarterly updates the Health Care Classification System (SKS). The updated version was published in mid-June 2024 to come into force on July 1, 2024. Six new surgical procedure codes, twenty new medical procedure codes, and nine new codes for diagnostic investigations were introduced concerning multiple areas, including diagnostic imaging, gastrointestinal, gynecology, orthopedics, and surgical procedures.

On June 19, 2024, the Swiss Federal Council granted partial approval to the new outpatient reimbursement system, consisting of the TARDOC catalog of individual service tariffs and the flat-rate system, which were developed independently. Adjustments were requested to ensure better coordination and adherence to cost neutrality. The full implementation of the new system is now postponed until 2026.

On June 13, 2024, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 196 and 092 with changes to be implemented no later than August 8, 2024. Five new procedure codes related to endoscopy, ENT, orthopedics, and spine, as well as seven new diagnostic codes were introduced.